Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

"Cost-effective" chlamydia tests to cut Danish incidence

This article was originally published in Clinica

Executive Summary

Screening couples for chlamydia with home diagnostic kits is likely to be cost effective as long as one partner is first identified as having the disease. This would make it more likely for the second partner to opt to take the home test. This is the conclusion of a recently published report by the Danish Centre for Evaluation and Health Technology Assessment (CEMTV).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061379

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel